Related Experiment Video
Updated: Feb 3, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Inhibitory effects of vasostatin-1 against atherogenesis
Yuki Sato1, Rena Watanabe1, Nozomi Uchiyama1
1Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Insights
This study shows vasostatin-1 inhibits key processes in atherosclerosis development, including inflammation and foam cell formation. Vasostatin-1 administration reduced atherosclerotic lesions in mice, suggesting its therapeutic potential for this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Immunology
Background:
- Vasostatin-1, a peptide derived from chromogranin A, is known to inhibit vasoconstriction and angiogenesis.
- Previous research indicated vasostatin-1 reduces monocyte adhesion to endothelial cells by down-regulating adhesion molecules.
Purpose of the Study:
- To investigate vasostatin-1 expression in human atherosclerotic lesions.
- To evaluate vasostatin-1's effects on inflammatory responses, macrophage foam cell formation, smooth muscle cell behavior, and extracellular matrix production.
- To assess vasostatin-1's impact on atherogenesis in apolipoprotein E-deficient (ApoE-/-) mice.
Main Methods:
- Vasostatin-1 expression analysis in human radial arteries.
- In vitro studies on human endothelial cells (HECs) and THP-1 derived macrophages assessing inflammatory markers (MCP-1, VCAM-1, E-selectin, IL-6) and M1 phenotype.
- Macrophage foam cell formation assays involving oxLDL, ACAT-1, CD36, and ABCA1.
- Human aortic smooth muscle cell (HASMC) assays for migration, proliferation, apoptosis, and ECM production (collagen-3, fibronectin, elastin, MMP-2, MMP-9) with AngII stimulation.
- In vivo study using ApoE-/- mice with chronic vasostatin-1 infusion.
Main Results:
- Vasostatin-1 was detected in human atherosclerotic lesions.
- Vasostatin-1 suppressed LPS-induced inflammatory responses in HECs and macrophages, including MCP-1, VCAM-1, E-selectin, IL-6, and M1 phenotype via NF-κB down-regulation.
- Vasostatin-1 inhibited oxLDL-induced foam cell formation by modulating ACAT-1, CD36, and ABCA1.
- In HASMCs, vasostatin-1 reduced AngII-induced migration and collagen/fibronectin expression (via ERK1/2, p38 inhibition) but increased elastin and MMPs (via Akt, JNK activation).
- Vasostatin-1 did not affect HASMC proliferation or apoptosis.
- ApoE-/- mice treated with vasostatin-1 showed reduced aortic atherosclerotic lesions, inflammation, macrophage infiltration, SMC content, and plasma glucose levels.
Conclusions:
- Vasostatin-1 exhibits significant inhibitory effects against multiple facets of atherogenesis.
- The findings suggest vasostatin-1 has potential as a novel therapeutic target for atherosclerosis.
- Vasostatin-1 demonstrates pleiotropic anti-atherogenic properties, impacting inflammation, lipid metabolism, and vascular remodeling.
Abstract:
Vasostatin-1, a chromogranin A (CgA)-derived peptide (76 amino acids), is known to suppress vasoconstriction and angiogenesis. A recent study has shown that vasostatin-1 suppresses the adhesion of human U937 monocytes to human endothelial cells (HECs) via adhesion molecule down-regulation. The present study evaluated the expression of vasostatin-1 in human atherosclerotic lesions and its effects on inflammatory responses in HECs and human THP-1 monocyte-derived macrophages, macrophage foam cell formation, migration and proliferation of human aortic smooth muscle cells (HASMCs) and extracellular matrix (ECM) production by HASMCs, and atherogenesis in apolipoprotein E-deficient (ApoE-/-) mice. Vasostatin-1 was expressed around Monckeberg's medial calcific sclerosis in human radial arteries. Vasostatin-1 suppressed lipopolysaccharide (LPS)-induced up-regulation of monocyte chemotactic protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin in HECs. Vasostatin-1 suppressed inflammatory M1 phenotype and LPS-induced interleukin-6 (IL-6) secretion via nuclear factor-κB (NF-κB) down-regulation in macrophages. Vasostatin-1 suppressed oxidized low-density lipoprotein (oxLDL)-induced foam cell formation associated with acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) and CD36 down-regulation and ATP-binding cassette transporter A1 (ABCA1) up-regulation in macrophages. In HASMCs, vasostatin-1 suppressed angiotensin II (AngII)-induced migration and collagen-3 and fibronectin expression via decreasing ERK1/2 and p38 phosphorylation, but increased elastin expression and matrix metalloproteinase (MMP)-2 and MMP-9 activities via increasing Akt and JNK phosphorylation. Vasostatin-1 did not affect the proliferation and apoptosis in HASMCs. Four-week infusion of vasostatin-1 suppressed the development of aortic atherosclerotic lesions with reductions in intra-plaque inflammation, macrophage infiltration, and SMC content, and plasma glucose level in ApoE-/- mice. These results indicate the inhibitory effects of vasostatin-1 against atherogenesis. The present study provided the first evidence that vasostatin-1 may serve as a novel therapeutic target for atherosclerosis.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
SN1 Reaction: Stereochemistry
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
Biological Effects of Radiation
SN1 Reaction: Kinetics
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...

